overall, study results show that post-legalization, a larger portion of patients needed observation without interventions (25 per cent versus 48 per cent), bloodwork and imaging studies decreased (53 per cent versus 12 per cent) and treatment with benzodiazepines increased (24 per cent versus 51 per cent).
“legalization was not associated with a change in the rate of cannabis-related ed visits in our study,” investigators write.
however, secondary outcomes that were considered as part of the review included the number of visits distributed by age, length of stay, co-ingestions and clinical course in the ed. additional research is needed to pin down details “regarding changing methods of cannabis ingestion and trends among specific age groups,” the study points out.
a study published last year involving 14
urban alberta eds following legalization between oct. 1, 2013, and july 31, 2019, found a small increase in physical visits and calls to a poison control centre.
“although only three of every 1,000 ed visits within the time period were attributed to cannabis, the number of cannabis-related ed presentations increased post-legalization by 3.1 (range is 11.5 to 12.6) visits per ed per month,” study authors wrote at the time. weed-related calls to poison control inched up and researchers “observed increases in cannabis-related hyperemesis, unintentional ingestion and individuals leaving the ed pre-treatment,” the study added.